ColdZyme Mouth & Throat Spray (Not Nasal Spray) - Cold Virus Treatment & Symptom Relief - Use at First Signs of a Cold - Menthol Flavour 20ml

Product Information

Kam, Y.W.; Okumura, Y.; Kido, H.; Ng, L.F.P.; Bruzzone, R.; Altmeyer, R. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS ONE. 2009, 4, e7870. [ Google Scholar] [ CrossRef][ Green Version] Chu, H.; Chan, J.F.; Yuen, T.T.; Shuai, H.; Yuan, S.; Wang, Y.; Hu, B.; Yio, C.C.Y.; Tsang, J.O.; Huagn, X.; et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: An observational study. Lancet Microbe 2020, 1, e14–e23. [ Google Scholar] [ CrossRef] Upon interaction of SARS-CoV-2 with pseudostratified epithelia, destruction of tissue culture integrity and a massive infection and intracellular C3 production were observed with concomitant anaphylatoxin C3a secretion. These effects were avoided by spraying ColdZyme onto human bronchial epithelial cells prior to infection with SARS-CoV-2. The protective effect from SARS-CoV-2 infection in vitro was observable up to 2 h following application of the ColdZyme mouth spray to the apical side of fully differentiated respiratory epithelia. A clinical trial on evaluation of ColdZyme in response to experimentally induced common cold applied 6 doses of the mouth spray daily, which corresponds to our time window of 1 to 2 h of effectiveness (clinical trial: COLDPREVII, https://clinicaltrials.gov/ct2/show/ {"type":"clinical-trial","attrs":{"text":"NCT02479750","term_id":"NCT02479750"}}NCT02479750). Börn eru sá hópur sem fær oftast kvef eða 7 til 10 sinnum áári 3 - en tíðnin lækkar með hækkandi aldri.

ColdZymehas a triple-action way of working; First the glycerol helps form a protective barrier in your mouth and throat. Press down on the pump and spray 2 puffs (1 dose) every two hours up to 6 times daily while you are exposed to the cold virus. NCT02522949, performed in 2013, registered post-trial in 2015, and changed in 2019 and 2020 [ 56, 57] National Institute of Health, U.S. National Library of Medicine. Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate Efficacy of CMS008618 for Common Cold. Available online: https://clinicaltrials.gov/ct2/show/NCT03794804 (accessed on 20 March 2021). Boots. ColdZyme ® OneCold Mouth Spray Against Common Cold. Available online: https://www.boots.com/wcsstore/cmsassets/Boots/Content/Products/Cold%20-%20CAT:%20A00000545/10183984.P/CZ_OneCold_leaflet_20140624_english.pdf (accessed on 20 March 2021).Zhirnov, O.P.; Ikizler, M.R.; Wright, P.F. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J. Virol. 2002, 76, 8682–8689. [ Google Scholar] [ CrossRef][ Green Version] The subcutaneous gamma-globulin treatment has been a great help for my son, but no matter how he was treated there were still some small symptoms left such as wounds in his oral mucosa and gums, which made him eat less and a constant runny nose that was not only annoying for him but which drove the whole family crazy. Early on in the pandemic, the Department for Transport suggested that airlines should offer a reduced food and drink service, and limit the sale of non-essential items.

Wat, Dennis. The common cold: a review of the literature, European Journal of Internal Medicine. 15 (2004): 79-88 Two smaller studies allowed us to calculate the % of users and non-users protected against virus [ 54, 55]. In the small pilot study in healthy volunteers (ENZY-001 or COLDPREV, performed in 2013) using the same protocol as COLDPREV II (protocol registered in 2015 and adapted twice post-trial in 2019 and 2020 [ 54, 56, 57]), the spray use before and after a nasal challenge with Rhinovirus-16 was assessed: the protective effect of 24-h pretreatment with CZ-MD, 6 times a day, prior to the standardized viral challenge, was compared with a placebo. More CZ-MD users became qPCR positive (20/23; 83%) and symptomatic (21/23; 91.3%) compared with placebo (16/23 (69.5%) [ 54]. Gudmundsdóttir A, Hilmarsson H, Stefansson B. Potential use of Atlantic cod trypsin in biomedicine. Biomed Res Int. 2013;2013:749078. https://doi.org/10.1155/2013/749078. Epub 2013 Feb 28. PMID: 23555095; PMCID: PMC3600245. Enzymatica AB. ColdZyme Wins Silver in Bizzie Baby Awards. Available online: https://coldzyme.co.uk/coldzyme-wins-silver-in-bizzie-baby-awards (accessed on 20 March 2021).Ark-Chem. Glycerol. Material Safety Data Sheet MSDS. Available online: http://ark-chem.co.jp/wp-content/uploads/SDS-E-GLYCERINE.pdf (accessed on 20 March 2021).

What I did not count on was the unexpected positive add-on effects upon using ColdZyme. His mouth ulcers drastically decreased which gave me a very different son. He can now eat the same food as the rest of us almost every day without having pain and his weight and height has increased. Shortly after beginning treatment the constant runny nose symptom also disappeared.Differences in regulations between medical devices and medicines in the European Union (definition of performance: “the ability of a device to achieve its intended purpose as stated by the manufacturer”; CE = Conformitè Europëeenne; NB: Notifying body; pK/pD = pharmacokinetics/pharmacodynamics); EEA = European Economic Area. EMA = European Medicines Agency; EU = European Union [ 3, 4, 5]. National Institute of Health, U.S. National Library of Medicine. History of Changes for Study: NCT02522949. Evaluation of ColdZyme ® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold (COLDPREV). Available online: https://clinicaltrials.gov/ct2/history/NCT02522949?V_1=View (accessed on 20 March 2021). Viral load and symptoms, assessed in the subsequent days, were collected as AUCs starting only 72 h after the viral challenge (so omitting the data of the first 3 days). Hence, although the manufacturer claims shorter and less symptoms and a reduced viral load, the selective choice of data restricted over a part of the study period and moreover limited to 21 CZ-MD versus 16 placebo participants, does not reliably allow such conclusions [ 54]. As mentioned above, the results were not confirmed in the larger placebo-controlled study COLDPREV II [ 51]. ColdZyme Mouth Spray is sugar-free and preservative-free. Coldzyme contains a marine enzyme that provides a protective barrier against colds in the oral cavity and throat. How to use: Use ColdZyme Mouth Spray for cold symptoms: Since IC C3 levels in treated and infected cultures were comparable to those of ColdZyme®-treated, uninfected samples (Fig. 1a–c, left), next, we analyzed and quantified C3 signals from more than 1000 cells/condition in UI, BA.1 and BA.4/5- and ColdZyme®/BA.1 and /BA.4/5-exposed, pseudostratified respiratory epithelia. We found highly significant differences in cell numbers and percentages of C3 +- (Fig. 1e) cells between cultures infected with the two SARS-CoV-2-VOCs compared to ColdZyme-treated/uninfected and ColdZyme®-treated/SARS-CoV-2-VOC-infected, primary respiratory cultures. These analyses demonstrate that infection going along with tissue destruction and intracellular C3 mobilization on 3 dpi induced in NHBE cultures upon SARS-CoV-2 interactions can be avoided by pre-treatment of epithelia with ColdZyme® mouth spray. ColdZyme® mouth spray maintains epithelial integrity upon SARS-CoV-2 infection of NHBE cultures